At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so I said that VCs generally expect that 1/3 of their investments will see great returns, 1/3 will see modest or no returns, and 1/3 will not be profitable.
VC Fred Wilson as Union Square Ventures recently analyzed his career in venture capital and posted his results. He’s got an enviable record of only 20% of deals failing to deliver, and more than 1/3 delivering a greater than 5x return.
Fred’s not into biotech, so I’d be hesitant about applying these numbers to biotechnology investing, and I’d be interested to see what the trends are in biotech VC.
I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University of Toronto. More details are available at the MBiotech website.
Bio-Rad’s got an interesting website up: RethinkPCR.
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in November 2007
*Drugs may be covered by more than one patent
|Tradename||Applicant||Generic Name||Patent Number||Patent Expiration|
|ANDRODERM||Watson Labs||testosterone||4,849,224||NOV 12,2007|
|ANDRODERM||Watson Labs||testosterone||4,983,395||NOV 12,2007|
|AVITA||Mylan Bertek||tretinoin||4,971,800||NOV 20,2007|
|ELOCON||Schering||mometasone furoate||4,775,529||NOV 21,2007|
|FLECTOR||Inst Biochem||diclofenac epolamine||4,948,805||NOV 09,2007|
|MERIDIA||Abbott||sibutramine hydrochloride||4,929,629||NOV 29,2007|
|MYLOTARG||Wyeth Pharms Inc||gemtuzumab ozogamicin||4,970,198||NOV 30,2007|
|STALEVO 100||Orion||carbidopa; entacapone; levodopa||4,963,590||NOV 27,2007|
|STALEVO 150||Orion||carbidopa; entacapone; levodopa||4,963,590||NOV 27,2007|
|STALEVO 50||Orion||carbidopa; entacapone; levodopa||4,963,590||NOV 27,2007|
|TOPROL-XL||Astrazeneca||metoprolol succinate||4,927,640||NOV 22,2007|
|TYLENOL (CAPLET)||Mcneil Cons||acetaminophen||4,968,509||NOV 06,2007|
|URSO 250||Axcan Scandipharm||ursodiol||4,859,660||NOV 19,2007|
|URSO FORTE||Axcan Scandipharm||ursodiol||4,859,660||NOV 19,2007|
Courtesy of DrugPatentWatch.com